Key Highlights
● Starbucks beat on profit at $0.80 a share but missed on Revenue of $9.10 billion.
● Gilead earned $2.55 a share and raised base-business guidance for a third time this year.
● Rivian narrowed its adjusted loss to $0.48 a share and raised EBITDA guidance.
● Reddit, Roblox and Twilio each dropped sharply after hours.
Amazon and Intel grabbed the headlines after Thursday's close, but a coffee chain, a snack maker, a drugmaker and an electric truck company also reported, with three of the four rising in extended trading.
A crowded evening
Thursday, October 29, ended with a packed after-hours session. Amazon (NASDAQ:AMZN) and Intel (NASDAQ:INTC) slid in extended trading and pulled Nasdaq-100 futures lower, according to market data. But the bell also brought results from Starbucks (NASDAQ:SBUX), Mondelez (NASDAQ:MDLZ), Gilead Sciences (NASDAQ:GILD) and Rivian (NASDAQ:RIVN), each telling a different story about the consumer and the economy.
The regular session had already been unusual. The S&P 500 slipped 23.59 points to 7,720.39 while more than 400 of its members rose. All the moves below took place in after-hours trading, where volumes are thinner and prices can shift through the evening.
Starbucks: profits beat, traffic soft
Starbucks topped profit forecasts, with adjusted Earnings of $0.80 a share, nine cents above consensus. Revenue of $9.10 billion fell short of the $9.22 billion expected, according to market data. The company pointed to soft traffic in the U.S. and in China comparisons.
Its outlook offered some comfort. Starbucks guided fiscal 2027 earnings to $3.15 to $3.25 a share, with a midpoint above the $3.14 consensus. The shares still slipped in extended trading. Reports differed on how far, but both pointed lower.
Mondelez: a snack maker's sweet spot
Mondelez, the company behind Oreo cookies and Cadbury chocolate, rose after hours on an earnings beat. Its Earnings Per Share topped estimates by seven cents, according to one report. One headline credited the stock's rise partly to its Dividend appeal.
The result fit a day when consumer staples had already been among the top-performing sectors in the regular session, according to market data.
Gilead: a third guidance raise
Gilead Sciences delivered one of the cleanest beats of the evening. Earnings of $2.55 a share topped the $2.21 consensus, and revenue of $8.30 billion beat the $7.81 billion forecast, according to market data. The company raised its full-year guidance for its base Business for a third time this year. CEO Daniel O'Day said the total increase is "$1.6 billion since the start of 2026."
HIV treatments grew solidly, and sales of Yeztugo, its prevention drug, nearly doubled. One source showed the stock higher after hours, while another headline said shares stayed flat, so reports differed on the move.
Rivian: an EV maker narrows its loss
Rivian rose in extended trading after third-quarter revenue of $2.155 billion beat the $2.02 billion consensus, according to market data. Its adjusted loss of $0.48 a share was narrower than the $0.61 to $0.64 analysts expected.
The company raised the low end of its delivery outlook to 67,000 to 70,000 vehicles and lifted its adjusted EBITDA guidance by $100 million at the midpoint, citing strong sales of its R2 model. The rally followed a rough regular session, in which market data indicated Rivian had touched a new 12-month low.
The broader after-hours picture
Not everyone fared so well. Reddit (NYSE:RDDT), Roblox (NYSE:RBLX) and Twilio (NYSE:TWLO) each dropped sharply after hours. Stryker (NYSE:SYK) tumbled after missing estimates, while DexCom (NASDAQ:DXCM) climbed on a beat and a new $1 billion buyback. Sandisk (NASDAQ:SNDK) was mixed after announcing an eight-for-one stock split.
What to watch
Friday's open will show whether these after-hours moves hold. Extended-trading prices can reverse once full Volume returns. Investors will also weigh the Employment Cost index at 8:30 a.m. ET, plus earnings from Chevron (NYSE:CVX) and AbbVie (NYSE:ABBV), before deciding whether Thursday's consumer and health care strength can carry into October's final session.






Please wait processing your request...